Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
This review focuses on the regulation of myocardial fatty acids and glucose metabolism in physiological and pathological conditions, and the role of L-carnitine and of its derivative, propionyl-L-carnitine. Fatty acids are the major oxidation fuel for the heart, while glucose and lactate provide the remaining need. Fatty acids in cytoplasm are transformed to long-chain acyl-CoA and transferred into the mitochondrial matrix by the action of three carnitine dependent enzymes to produce acetyl-CoA through the beta-oxidation pathway. Another source of mitochondrial acetyl-CoA is from the oxidation of carbohydrates. The pyruvate dehydrogenase (PDH) complex, the key irreversible rate limiting step in carbohydrate oxidation, is modulated by the intra-mitochondrial ratio acetyl-CoA/CoA. An increased ratio results in the inhibition of PDH activity. A decreased ratio can relieve the inhibition of PDH as shown by the transfer of acetyl groups from acetyl-CoA to carnitine, forming acetylcarnitine, a reaction catalyzed by carnitine acetyl-transferase. This activity of L-carnitine in the modulation of the intramitochondrial acetyl-CoA/CoA ratio affects glucose oxidation. Myocardial substrate metabolism during ischemia is dependent upon the severity of ischemia. A very severe reduction of blood flow causes a decrease of substrate flux through PDH. When perfusion is only partially reduced there is an increase in the rate of glycolysis and a switch from lactate uptake to lactate production. T…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Compared with resting conditions, exercising at intensities greater than 75% VO2max have been shown to reduce free carnitine concentrations in working muscle by ~80% [37].”
From Understanding the factors that effect maximal fat oxidation. (2018) · cites this paper as [37]
In the citing paper
“Fatty acid oxidation is directly influenced by HAD activity [1, 18] in addition to the transport of FAs across the cellular and mitochondrial membranes [24, 37, 38].”
From Understanding the factors that effect maximal fat oxidation. (2018) · cites this paper as [37]
In the citing paper
“The result of the abundant fast glycolysis derived acetyl-carnitine concentrations at high exercise intensities directly limits FA-acetyl transport into the mitochondria, limiting FAox potential [24, 37, 38].”
From Understanding the factors that effect maximal fat oxidation. (2018) · cites this paper as [37]
In the citing paper
“Therefore, as exercise intensity increases beyond moderate intensity, carnitine can be a limitation of FA substrate utilization due to the buffering of glycolytic acetyl-carnitine during high intensity exercise [24, 37, 38].”
From Understanding the factors that effect maximal fat oxidation. (2018) · cites this paper as [37]
In the citing paper
“The transport protein known as carnitine palmitoyltransferase-1 (CPT-1) is located on the outer mitochondrial membrane and is responsible for the transportation of LCFAs into the mitochondria shown in Fig. 1 [35, 37, 38].”
From Understanding the factors that effect maximal fat oxidation. (2018) · cites this paper as [37]
Citations
Cites
Relationship Between Carbohydrate and Lipid Metabolism and the Energy Balance of Heart Muscle
Neely, J. R., & Morgan, H. E. (1974) · Annual Review of Physiology · doi:10.1146/annurev.ph.36.030174.002213 · Cited by 1,261
Molecular cloning and characterization of an insulin-regulatable glucose transporter
James, D. E., Strube, M., & Muecdler, M. (1989) · Nature · doi:10.1038/338083a0 · Cited by 903
Molecular Biology of Mammalian Glucose Transporters
Bell, G. I., Kayano, T., Buse, J. B., Burant, C. F., Takeda, J., Lin, D., Fukumoto, H., & Seino, S. (1990) · Diabetes Care · doi:10.2337/diacare.13.3.198 · Cited by 853
Tani, M., & Neely, J. R. (1989) · Circulation Research · doi:10.1161/01.res.65.4.1045 · Cited by 765
Kudo, N., Barr, A. J., Barr, R. L., Desai, S., & Lopaschuk, G. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17513 · Cited by 564
Regulation of fatty acid oxidation in the mammalian heart in health and disease
Lopaschuk, G. D., Belke, D. D., Gamble, J., Toshiyuki, I., & Schönekess, B. O. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)00082-4 · Cited by 554
Fatty acid homeostasis in the normoxic and ischemic heart
van der Vusse, G. J., Glatz, J. F., Stam, H. C., & Reneman, R. S. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.4.881 · Cited by 516
RELATION BETWEEN SERUM-FREE-FATTY-ACIDS AND ARRHYTHMIAS AND DEATH AFTER ACUTE MYOCARDIAL INFARCTION
OLIVER, M. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92163-6 · Cited by 515
Saddik, M., & Lopaschuk, G. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92956-x · Cited by 432
Energy metabolism of the heart: From basic concepts to clinical applications applications
Taegtmeyer, H. (1994) · Current Problems in Cardiology · doi:10.1016/0146-2806(94)90008-6 · Cited by 394
Cited by
Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., & McMullen, J. R. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1477-x · Cited by 708
Carnitine and Acylcarnitines: Pharmacokinetic, Pharmacological and Clinical Aspects
Reuter, S. E., & Evans, A. M. (2012) · Clinical Pharmacokinetics · doi:10.1007/bf03261931 · Cited by 493
“Concentrations of acyl-CoA have been shown to regulate fatty acid oxidation; this is thought to be mediated via malonylCoA, a potent inhibitor of carnitine acyltransferase activity, which is the rate-limiting step in fatty acid oxidation.([107-111]) Malonyl-CoA is synthesized from acetyl-CoA by acetyl-CoA carboxylase,…”
BackgroundMitochondrial Metabolism in Aging Heart
Lesnefsky, E. J., Chen, Q., & Hoppel, C. L. (2016) · Circulation Research · doi:10.1161/circresaha.116.307505 · Cited by 353
“From acetylCoA, citrate synthase produces citrate using oxaloacetate from the tricarboxylic acid cycle located in the matrix space.(4)”
BackgroundMethodInsulin-Resistant Cardiomyopathy
Witteles, R. M., & Fowler, M. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.021 · Cited by 351
Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes
Wilson, R. D., & Islam, M. S. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70739-9 · Cited by 289
The mitochondrial carnitine/acylcarnitine carrier: Function, structure and physiopathology
Indiveri, C., Iacobazzi, V., Tonazzi, A., Giangregorio, N., Infantino, V., Convertini, P., Console, L., & Palmieri, F. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.008 · Cited by 262
Understanding the factors that effect maximal fat oxidation.
Purdom, T., Kravitz, L., Dokladny, K., & Mermier, C. (2018) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-018-0207-1 · Cited by 247
Yin, P., Zhao, X., Li, Q., Wang, J., Li, J., & Xu, G. (2006) · Journal of Proteome Research · doi:10.1021/pr060256p · Cited by 152
Heart Metabolic Disturbances in Cardiovascular Diseases
Carvajal, K., & Moreno‐Sánchez, R. (2003) · Archives of Medical Research · doi:10.1016/s0188-4409(03)00004-3 · Cited by 163
“In this sense, beneficial effects of propionyl-L-carnitine in volume-overloaded rat hearts are attributed to simultaneous relief of PDHa inhibition and activation of CPT-I, resulting in increase in mechanical activity of hypertrophied hearts (11).”
BackgroundInfluentialAugustus, A. S., Kako, Y., Yagyu, H., & Goldberg, I. J. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00298.2002 · Cited by 139
“FATTY ACIDS (FA) are an important fuel source for heart and skeletal muscle, providing over 70% of the energy needs for cardiac function (2, 5, 33).”
BackgroundCalabrese, V., Stella, A. G., Calvani, M., & Butterfield, D. A. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.03.027 · Cited by 143
“[29] Calvani M, Reda E, Arrigoni-Martelli E.”
BackgroundSelf-citationAugustus, A., Yagyu, H., Haemmerle, G., Bensadoun, A., Vikramadithyan, R. K., Park, S.-Y., Kim, J. K., Zechner, R., & Goldberg, I. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401028200 · Cited by 121
Levandi, T., León, C., Kaljurand, M., García‐Cañas, V., & Cifuentes, A. (2008) · Analytical Chemistry · doi:10.1021/ac8006329 · Cited by 117
Genomics of the Human Carnitine Acyltransferase Genes
van der Leij, F. R., Huijkman, N., Boomsma, C. M., Kuipers, J. R. G., & Bartelds, B. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3055 · Cited by 116
High-resolution analysis of metabolic cycles in the intertidal mussel Mytilus californianus
Connor, K. M., & Gracey, A. Y. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00453.2011 · Cited by 89
Mingorance, C., Rodríguez‐Rodríguez, R., Justo, M. L., Herrera, M. D., & de Sotomayor, M. Á. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00387.x · Cited by 93
Jensen, P. R., Peitersen, T., Karlsson, M. G., Zandt, R. I. ‘., Gisselsson, A., Hansson, G., Meier, S., & Lerche, M. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066407 · Cited by 90
Ji, L., Zhang, X., Liu, W., Huang, Q., Yang, W., Fu, F., Ma, H., Su, H., Wang, H., Wang, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069910 · Cited by 82
“In normal conditions, the heart predominantly uses long-chain fatty acid (LCFA, 60–70%) due to the high energy yield per molecule of substrate metabolized [7,8].”
BackgroundJiang, X., Goldberg, I. J., & Park, T. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_2 · Cited by 75
Ueland, T., Svardal, A. M., Øie, E., Askevold, E. T., Nymoen, S. H., Bjørndal, B., Dahl, C. P., Gullestad, L. L., Berge, R. K., & Aukrust, P. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.04.150 · Cited by 74
“Carnitine plays a critical role in FA transport into the mitochondria, and may reverse the inhibition of pyruvate dehydrogenase, allowing for improved coupling between glycolysis and glucose oxidation within the myocardium [8].”
BackgroundMechanick, J. I., Brett, E. M., Chausmer, A. B., Dickey, R. A., Wallach, S., Bergman, D. A., Garber, J. R., Hamilton, C. R., Handelsman, Y., Holdy, K. E., et al. (2003) · Endocrine Practice · doi:10.4158/ep.9.5.417 · Cited by 73
Dodd, M. S., Atherton, H. J., Carr, C. A., Stuckey, D. J., West, J. A., Griffin, J. L., Radda, G. K., Clarke, K., Heather, L. C., & Tyler, D. J. (2014) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.114.001857 · Cited by 68
Chen, Y., Li, Q., Pan, C., Yan, L., Fan, J., He, K., Sun, K., Liu, Y., Chen, Q., Bai, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep11802 · Cited by 66
Bene, J., Márton, M., Mohás, M., Bagosi, Z., Bujtor, Z., Oroszlán, T., Gasztonyi, B., Wittmann, I., & Melegh, B. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000345759 · Cited by 71
Emran, T., Chowdhury, N. I., Sarker, M., Bepari, A. K., Hossain, M., Rahman, G. M. S., & Reza, H. M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112139 · Cited by 61
Rasmussen, J., Nielsen, O. W., Lund, A. M., Køber, L., & Djurhuus, H. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9488-8 · Cited by 64
“This was shown to impair myocardial performance during work in rat hearts (Calvani et al 2000; Broderick et al 1995).”
BackgroundJones, A. E., Puskarich, M. A., Shapiro, N. I., Guirgis, F. W., Runyon, M., Adams, J. Y., Sherwin, R., Arnold, R., Roberts, B. W., Kurz, M. C., et al. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.6076 · Cited by 60
“1) Disease severity, median (IQR) Enrollment SOFA score 12 (8-14) 11 (9-15) 12 (8-14) 11 (9-13) Enrollment APACHE II score 23 (16-28) 25 (17-29) 24 (18-30) 19 (14-25) Enrollment lactate level, mg/dL 32.”
Traditional Chinese medicine enhances myocardial metabolism during heart failure
Shao-mei, W., Ye, L., & Wang, L. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112538 · Cited by 61
Flores, J. E., McFarland, L. M., Vanderbilt, A. N., Ogasawara, A. K., & Williams, S. (2008) · Molecular Imaging and Biology · doi:10.1007/s11307-008-0137-4 · Cited by 57
“perhaps consistent with the notion that sevoflurane causes less metabolic perturbance than isoflurane and the knowledge that the myocardium can switch rapidly between glucose and other energy sources under hormonal influences with insulin levels being the key [26].”
Niu, Y., Hauton, D., & Evans, R. D. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.061473 · Cited by 54
“Most (∼70%) of the cardiac energy requirement is supplied by fatty acid (FA) oxidation under normal physiological workload conditions (Lopaschuk et al. 1994; Calvani et al. 2000; van der Vusse et al. 2000).”
BackgroundCritical update for the clinical use of L-carnitine analogs in cardiometabolic disorders
Herrera, M. D., Mingorance, Rodriguez, Justo, M. L., & de Sotomayor (2011) · Vascular Health and Risk Management · doi:10.2147/vhrm.s14356 · Cited by 60
Real‐time cardiac metabolism assessed with hyperpolarized [1‐13C]acetate in a large‐animal model
Flori, A., Liserani, M., Frijia, F., Giovannetti, G., Lionetti, V., Casieri, V., Positano, V., Aquaro, G. D., Recchia, F. A., Santarelli, M. F., et al. (2014) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1618 · Cited by 53
“The lack of [1-(13)C]acetyl CoA could also be attributed to the role of this molecule as an intermediate stage of the (13)Cacetate metabolic pathway (15,17).”
BackgroundZhou, S., Zhou, S.-F., Huang, H., Chen, J., Huang, M., & Liu, P. (2006) · Journal of Proteome Research · doi:10.1021/pr050456l · Cited by 49
Nishikido, T., Oyama, J., Shiraki, A., Komoda, H., & Node, K. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002863 · Cited by 49
Garg, N. J., Gerstner, Á., Bhatia, V., DeFord, J. H., & Papaconstantinou, J. (2004) · Biochemical Journal · doi:10.1042/bj20040356 · Cited by 50
Micronutrients in Chronic Heart Failure
Krim, S. R., Campbell, P. M. F., Lavie, C. J., & Ventura, H. O. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0118-4 · Cited by 52
Ibrahim, W. H., Bailey, N. G., Sunvold, G. D., & Bruckner, G. G. (2003) · American Journal of Veterinary Research · doi:10.2460/ajvr.2003.64.1265 · Cited by 43
Glycine Propionyl-L-carnitine Modulates Lipid Peroxidation and Nitric Oxide in Human Subjects
Bloomer, R. J., Tschume, L. C., & Smith, W. A. (2009) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.79.3.131 · Cited by 42
“Carnitine is a natural component of mammalian tissue and is a necessary factor in the utilization of longchain fatty acids within the mitochondria for energy production [7].”
BackgroundZhang, Y., Fu, Y., Jiang, T., Liu, B., Sun, H., Zhang, Y., Fan, B., Li, X., Qin, X., & Zheng, Q. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.771940 · Cited by 44
“Some other experimental studies have given another explanation for the improved carbohydrate metabolism, that LCA supplementation can reduce the ratio of acetyl-CoA to free CoA in the mitochondria, thereby stimulating the activity of pyruvate dehydrogenase (PDH) (Calvani et al., 2000).”
BackgroundMingorance, C., Duluc, L., Chalopin, M., Simard, G., Ducluzeau, P., Herrera, M. D., de Sotomayor, M. Á., & Andriantsitohaina, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034268 · Cited by 42
“Although the reduced toxic effects of incomplete boxidation byproducts or the enhanced NO production observed in PLC-treated animals may well be pointed out as responsible for such effects in myocardial function, the cardioprotective action of PLC in ischemic heart has also been traditionally related to an improvement…”
BackgroundMcCarty, M. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073321 · Cited by 42
“In the setting of ischemic coronary disease, it is known that carnitine helps to limit lactic acid production in cardiomyocytes by disinhibiting pyruvate dehydrogenase (owing to increased conversion of acetyl-coA to acetyl-carnitine, and a consequent decline in the acetyl-coA/free coA ratio that regulates pyruvate deh…”
BackgroundIncreased risk of sudden death in untreated primary carnitine deficiency
Rasmussen, J., Dunø, M., Lund, A. M., Steuerwald, U., Hansen, S., Joensen, H. D., Køber, L., & Nielsen, O. W. (2019) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12158 · Cited by 40
“Mean age, years (range) 28 (21-37) 22 (1-43) 23 (1-43)”
Rasmussen, J., Køber, L., Lund, A. M., & Nielsen, O. W. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9640-0 · Cited by 39
L-carnitine for the Treatment of Acute Myocardial Infarction
DiNicolantonio, J. J., Niazi, A. K., McCarty, M. F., Lavie, C. J., Liberopoulos, E. N., & O’Keefe, J. H. (2014) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0710 · Cited by 37
Maarman, G. J., Marais, E., Lochner, A., & Toit, E. F. D. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6377-1 · Cited by 38
Steinmetz, M., Quentin, T., Poppe, A., Paul, T., & Jux, C. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0520-0 · Cited by 41
Effects of Tyrosine and Tryptophan in Rats with Diet-Induced Obesity
Александрович, Ш. В., Вячеславович, Т. Н., Apryatin, S. A., Александровна, Ш. А., Balakina, A. S., Александрович, Р. Н., Gmoshinski, I. V., & Nikityuk, D. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052429 · Cited by 36
“LDH can be considered as a marker of the intensification fatty acids beta-oxidation manifesting in an increase in the acetyl-CoA/CoA ratio in the mitochondria of myocytes and an increase in the level of pyruvate in the cytoplasm [26].”
BackgroundBakermans, A. J., van Weeghel, M., Denis, S. W., Nicolay, K., Prompers, J. J., & Houten, S. M. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9604-4 · Cited by 35
“In addition, low free carnitine levels found in other pathologies such as ischemia and cardiac hypertrophy have been associatedwith reduced FAO (Calvani et al 2000).”
BackgroundLiu, L., Shi, Y., Li, Z.-L., Zuo, L., Tang, M., Jing, Z., Zhao, H., Xue, P., Zhou, L., Du, Q., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00502 · Cited by 34
Wang, X., West, J. A., Murray, A. J., & Griffin, J. L. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00128 · Cited by 36
Metabolic Therapy of Heart Failure: Is There a Future for B Vitamins?
Piquereau, J., Boitard, S. E., Ventura‐Clapier, R., & Mericskay, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010030 · Cited by 35
“At the outer mitochondrial membrane, long-chain FAs are transformed into fatty acyl-CoA by long-chain fatty acyl-CoA synthetase and are then transported into the mitochondrial matrix through the carnitine palmitoyltransferase (CPT) system [38].”
BackgroundThe role of histone deacetylases in cardiac energy metabolism in heart diseases
Yu, Q., Zhao, G., Liu, J., Peng, Y., Xu, X., Zhao, F., Shi, Y., Jin, C., Zhang, J., & Wei, B. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155532 · Cited by 34
Mapping and SNP analysis of bovine candidate genes for meat and carcass quality
Haegeman, A., Williams, J. L., Law, A. S., Zeveren, A. V., & Peelman, L. J. (2003) · Animal Genetics · doi:10.1046/j.1365-2052.2003.01008.x · Cited by 33
β-Alanine and orotate as supplements for cardiac protection
McCarty, M. F., & DiNicolantonio, J. J. (2014) · Open Heart · doi:10.1136/openhrt-2014-000119 · Cited by 33
“oxidation of pyruvate, hence lessening glycolytic generation of lactic acid.(26) To date, clinical studies evaluating the utility of”
BackgroundLee, S.-Y., Ku, H.-C., Kuo, Y., Chiu, H.-L., & Su, M. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0125-3 · Cited by 33
“During myocardial reperfusion, fatty acid oxidation quickly recovers and becomes the major source of energy [34].”
BackgroundGómez, L. A., Heath, S.-H. D., & Hagen, T. M. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.01.007 · Cited by 31
“…a classical free radical terminating molecule, nevertheless, it decreases the formation of nitro-tyrosine protein adducts in alcohol-induced brain damage (Rump et al., 2010), and limits oxidative damage in the heart following ischemia/ reperfusion injury (Calvani et al., 2000; Cui et al., 2003).”
BackgroundO’Brien, D. R., Chunduri, P., Iyer, A., & Brown, L. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00480.x · Cited by 30
L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review
Wang, W., Pan, D., Liu, Q., Chen, X., & Wang, S. (2024) · Nutrients · doi:10.3390/nu16081232 · Cited by 31
“The long-chain fatty acids are transported to the mitochondrial matrix, where beta-oxidation of the fatty acids occurs and adenosine triphosphate (ATP) is produced [192].”
BackgroundEffect of L-carnitine on the hepatic transcript profile in piglets as animal model
Keller, J., Ringseis, R., Priebe, S., Guthke, R., Kluge, H., & Eder, K. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-76 · Cited by 31
“Several studies have already shown that carnitine supplementation increases glucose disposal and glucose oxidation in animals as well as in healthy and diabetic patients [12,24,25] due to activation of the pyruvate dehydrogenase complex [26].”
Matyal, R., Sakamuri, S., Wang, A. Y., Mahmood, E., Robich, M. P., Khabbaz, K. R., Hess, P. E., Sellke, F. W., & Mahmood, F. U. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.08.023 · Cited by 26
Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome
Khan, M. S., Kim, H., Kim, R., Yoon, S. H., & Kim, S. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087454 · Cited by 27
“Hence, lipid-induced defects in glucose transport caused by IR affect insulin sensitivity in muscle but do not affect a lipid-induced reduction in pyruvate dehydrogenase activity [90].”
BackgroundCalò, L., Davis, P. A., Pagnin, E., Bertipaglia, L., Naso, A., Piccoli, A., Corradini, R., Spinello, M., Savica, V., & Libera, L. D. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm707 · Cited by 26
“One potential area of investigation may come from carnitine’s well-documented effects on mitochondrial glucose metabolism [34].”
BackgroundLin, X., Brown, K. R., Woodworth, J. C., Shim, K. S., Johnson, B. J., & Odle, J. (2008) · Journal of Nutrition · doi:10.3945/jn.108.095638 · Cited by 25
Chen, C., Lin, H.-Y., Chen, Y., Ko, Y. J., Liu, Y. J., Chen, Y. H., Walzem, R. L., & Chen, S. (2017) · Poultry Science · doi:10.3382/ps/pex015 · Cited by 24
Impact of Ischemia on Cellular Metabolism
Gourdin, M. J., & Dubois, P. (2013) · InTech eBooks · doi:10.5772/54509 · Cited by 27
“[4],[24] In more severe ischemia, the lack of the cofactors NADH,H+ and FAD+, which are normally regenerated through oxi‐ dative phosphorylation, completely inhibits acyl-CoenzymeA (acyl-CoA) dehydrogenase and 3-hydroxyacyl-CoA dehydrogenase, which are key beta-oxidation enzymes.”
BackgroundKim, K., Shin, W., Choi, M. S., Cho, J., Park, H., Yoo, H. H., & Song, M. (2020) · Acupuncture in Medicine · doi:10.1177/0964528420912259 · Cited by 22
Weyenberg, S. V., Buyse, J. G., & Janssens, G. (2008) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2008.00807.x · Cited by 22
Qian, Q.-H., Song, Y., Zhang, Y., Xue, H., Zhang, W., Han, Y., Wāng, Y., & Xu, D. (2024) · Environment International · doi:10.1016/j.envint.2024.108488 · Cited by 21
Zong, X., Fan, Q., Yang, Q., Pan, R., Zhuang, L., Xi, R., Zhang, R., & Tao, R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.907997 · Cited by 22
“Carnitine is an important transporter to carry fatty acid into mitochondria (21, 22).”
BackgroundFathizadeh, H., Milajerdi, A., Reiner, Ž., Kolahdooz, F., Chamani, M., Amirani, E., & Asemi, Z. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190830154336 · Cited by 20
Oxidative Stress and Nerve Function After Cardiopulmonary Bypass in Patients With Diabetes
Matyal, R., Sakamuri, S., Huang, T. W., Owais, K., Parikh, S. M., Khabbaz, K. R., Wang, A. Y., Sellke, F. W., & Mahmood, F. U. (2014) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.06.041 · Cited by 19
“hronic hyperglycemia and insulin resistance resulting Cfrom type 2 diabetesmellitus (DM) are associated with inhibition of glycolysis, impaired fatty acidmetabolism, and inflammation [1, 2].”
BackgroundWang, X., Wang, D., Yu, X., Zhang, G., Wu, J., Zhu, G., Su, R., & Lv, J. (2016) · Molecular BioSystems · doi:10.1039/c6mb00080k · Cited by 18
Mazdeh, M., Abolfathi, P., Sabetghadam, M., Mohammadi, Y., & Mehrpooya, M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2493053 · Cited by 18
“Trans-porting the long-chain fatty acids from the cell cytoplasm to the mitochondrial matrix, where β -oxidation of fatty acids and adenosine triphosphate (ATP) production happens, is the main function of the L-carnitine [17].”
Liu, L., Wang, W., Meng, X., Gao, J., Wu, H., Wang, P., Wu, W., Wang, L., Ma, L., & Zhang, W. (2010) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-010-0039-1 · Cited by 17
“, L-3-hydroxyacyl-coenzyme A dehydrogenase, a protein related to fatty acid oxidation was down-regulated; whereas glyceraldehyde-3phosphate dehydrogenase, an important enzyme in glycolysis was up-regulated in the hypertrophied hearts, which is consistent with energymetabolism pattern of the embryo heart [4] or the dat…”
Liu, Z., vonBargen, R. U., Kendricks, A. L., Wheeler, K., Leão, A. C., Sankaranarayanan, K., Dean, D. A., Kane, S. S., Hossain, E., Pollet, J. B. K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42247-w · Cited by 18
The Carnitine Transporter Network: Interactions with Drugs
Indiveri, C., Pochini, L., Oppedisano, F., & Tonazzi, A. (2010) · Current Chemical Biology · doi:10.2174/2212796811004020108 · Cited by 20
“Thus, the switch has an important role not only under physiological conditions, but also under pathological conditions, such as during ischemia [76-78].”
BackgroundDambrova, M., Chłopicki, S., Liepinsh, E., Kirjanova, O., Gorshkova, O., Kozlovski, V. I., Uhlén, S., Liepiņa, I., Petrovska, R., & Kalvinsh, I. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0925-6 · Cited by 17
Wang, W., Wang, Z., Yang, X., Song, W., Chen, P., Gao, Z., Wu, J., & Huang, F. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121115 · Cited by 16
Raij, T., & Raij, K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1358404 · Cited by 16
How Perturbated Metabolites in Diabetes Mellitus Affect the Pathogenesis of Hypertension?
Ning, Z., Song, Z., Wang, C., Peng, S., Wan, X., Liu, Z., & Lü, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.705588 · Cited by 15
Targeting Mitochondrial Metabolism to Save the Failing Heart
Schenkl, C., Heyne, E., Doenst, T., Schulze, P. C., & Nguyễn, T. D. (2023) · Life · doi:10.3390/life13041027 · Cited by 13
“In addition to stimulating uptake and oxidation of fatty acids, L-carnitine may also increase glucose oxidation by stimulating pyruvate dehydrogenase in conditions of high levels of free FAs [162].”
BackgroundThe Role of Micronutrients and Macronutrients in Patients Hospitalized for Heart Failure
Trippel, T. D., Anker, S. D., & von Haehling, S. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.05.001 · Cited by 14
Wong, G. K., Pehora, C., & Crawford, M. W. (2016) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-016-0797-5 · Cited by 13
Zhou, J., Hou, H., Song, Y., Zhou, X., Chen, H., Zhang, L., Xue, H., Yang, Q., & He, G. (2024) · Biomolecules · doi:10.3390/biom14050532 · Cited by 12
“Fatty acids are the main oxidative fuel of the heart, contributing 70–80% of the energy related to mitochondrial oxidative phosphorylation and ATP production [20]. to mitochondrial oxidative phosphorylation and ATP production [20].”
BackgroundAnalysis of Liver Transcriptome in Broilers with Ascites and Regulation by L-Carnitine
Wang, Y., Guo, Y., Ning, D., Peng, Y., Yang, Y., & Liu, D. (2012) · The Journal of Poultry Science · doi:10.2141/jpsa.0120124 · Cited by 12
“The studies have already shown that carnitine supplementation increases glucose disposal and glucose oxidation in animals as well as in healthy and diabetic patients due to activation of the pyruvate dehydrogenase complex (Calvani et al., 2000; Van Weyenberg et al., 2009).”
BackgroundXie, H., Xu, G., Aa, J., Gu, S., & Gao, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.671161 · Cited by 12
The protective effect of L-carnitine on ischemia-reperfusion heart
Jiang, X., Qiutang, Z., & Wang, L. (2006) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/bf02895812 · Cited by 12
Mitochondrial disorders in chagasic cardiomyopathy
Nisha, G. (2005) · Frontiers in bioscience · doi:10.2741/1624 · Cited by 12
Macrophage-Specific Lactate Dehydrogenase Expression Modulates Inflammatory Function In Vitro
Lu, Y., Osis, G., Zmijewska, A. A., Traylor, A., Thukral, S., Wilson, L. S., Barnes, S., George, J. F., & Agarwal, A. (2024) · Kidney360 · doi:10.34067/kid.0000000630 · Cited by 11
“Notably, acetylcar-nitine, implicated in the activation of the in fl ammatory response, 34 was signi fi cantly downregulated in IFN-g – activated LDHA KO macrophages.”
Fujita, K., Desmond, P. F., Blondelle, J., Soták, M., Rajan, M. R., Clark, M., Estève, É., Chan, Y., Gu, Y., Dato, V. A., et al. (2025) · Circulation Heart Failure · doi:10.1161/circheartfailure.124.011867 · Cited by 11
Metabolic Intersection of Cancer and Cardiovascular Diseases: Opportunities for Cancer Therapy
Hoang, G., Nguyen, K. T., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_18 · Cited by 11
Carnitine and coenzyme Q10 levels in individuals with Prader–Willi syndrome
Miller, J. L., Lynn, C. H., Shuster, J. J., & Driscoll, D. J. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33887 · Cited by 11
“An elevated esterified-to-free carnitine ratio occurs when mitochondrial energy metabolism is impaired, resulting in an increased load of short chain organic acids esterified to CoA, which are transesterified to carnitine for export from muscle tissue into the circulation [Calvani et al., 2000].”
BackgroundNakajima, T., Fukuda, T., Shibasaki, I., Obi, S., Sakuma, M., Abe, S., Fukuda, H., Toyoda, S., & Nakajima, T. (2024) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2024.101386 · Cited by 10
“L-carnitine also helps overcome FA oxidation defects associated with metabolic diseases [9] and improves energy metabolism linked to mitochondrial disorders in diseases such as heart failure (HF) [10].”
BackgroundWang, S.-X., Tan, L., Wang, J., & Zhong, J.-Q. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.01.025 · Cited by 10
Liu, Y., & van der Leij, F. R. (2010) · Pediatric Research · doi:10.1203/pdr.0b013e318205178b · Cited by 11
“appreciated (16,17), in addition to its function as potential”
BackgroundBroderick, T. L., Cifuentes, J., Green, D., & Paulson, D. J. (2001) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-79-10-892 · Cited by 10
McCarty, M. F. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00232-9 · Cited by 11
“This appears to be the best current explanation for carnitine’s clinical utility in angina [95,96].”
BackgroundIschemic postconditioning alters the gene expression pattern of the ischemic heart
Csonka, C., Szűcs, G., Varga-Orvos, Z., Bencsik, P., Csont, T., Zvara, Á., Puskás, L. G., & Ferdinándy, P. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370213511017 · Cited by 8
Kim, H. J., Kim, H. S., Jung, J. R., Kim, H. Y., Lynch, C. I., & Park, W. K. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004637 · Cited by 8
Small molecule mediators of host-T. cruzi-environment interactions in Chagas disease
Kwakye-Nuako, G., Middleton, C. E., & McCall, L. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012012 · Cited by 8
Metadata
- Authors
- Calvani, M., Reda, E., & Arrigoni-Martelli, E.
- Affiliations
- Sigma Tau (Italy) (IT)
- Venue
- Basic Research in Cardiology
- Published
- 2000-04-01
- Volume
- 95
- Issue
- 2
- Pages
- 75-83
- ISSN
- 0003-9217 (ISSN-L)
- 0300-8428
- 1435-1803
- OpenAlex
- W1991824137
- Cited by
- 155
- References
- 57
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 9 · 2023: 4 · 2022: 9 · 2021: 10 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 6 · 2015: 8 · 2014: 8 · 2013: 7 · 2012: 13
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Basic Research in Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- L-carnitine, propionylcarnitine, myocardial metabolism, fatty acid oxidation, glucose oxidation, pyruvate dehydrogenase, carnitine acetyltransferase, acylcarnitines, myocardial ischemia, reperfusion, cardiac hypertrophy, cardioprotection, lactate
- MeSH terms
- Animals, Carnitine, Fatty Acids, Humans, Myocardium, Oxidation-Reduction, Myocardial Reperfusion Injury, Myocardial Ischemia, Carbohydrate Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.